| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0029 | 1 |